In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of R&D, heads of regulatory affairs, and commercial directors from agrigenomics technology suppliers, seed businesses, and agricultural biotechnology corporations were examples of supply-side sources. Chief scientific officers of agricultural research institutes, directors of crop science, administrators of animal breeding programs, and procurement leaders from commercial farms, agricultural cooperatives, and food production corporations were examples of demand-side sources. In addition to gathering information on technology adoption trends, genomic service pricing strategies, and regulatory compliance dynamics, primary research verified market segmentation and product pipeline timescales.
Primary Respondent Breakdown:
By Designation: C-level Primaries (32%), Director Level (31%), Others (37%)
By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)
Revenue mapping and technology adoption volume analysis were used to determine the global market valuation. The methodology comprised:
Finding more than fifty major technology suppliers and service firms in North America, Europe, Asia-Pacific, and Latin America
Product mapping among genotyping, gene editing, polymerase chain reaction (PCR), and next-generation sequencing (NGS) technology categories
Examination of reported and estimated yearly income for agrigenomics portfolios
coverage of producers and service providers that will account for 72–78% of the world market in 2024
Extrapolation for agricultural improvement, livestock breeding, plant pathology, and environmental sustainability applications employing top-down (company revenue validation) and bottom-up (technology deployment volume × ASP by country/region) methods